GOSS

Conviction 4HealthcareScan · Thu, Jun 25, 2026

GOSS$0.1619-4.20%

ResistanceSupportVol 14

Vol MA14 17.4M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Gossamer Bio, Inc.PHARMACEUTICAL PREPARATIONSwww.gossamerbio.com ↗

Price0.1619

Change-4.20%

Gap+0.06%

Rel volume1.21×

Avg volume16.06M

Avg $ vol2.82M

SMA 200.1775

SMA 500.2689

SMA 2001.72

Price vs 50-39.79%

Price vs 200-90.58%

MA stackbearish

50/200 cross—

Supertrenddown · 0.2279

RSI (14)35

MACD hist0.01

MACD cross—

Stoch %K / %D37 / 46

ADX (14)29

+DI / −DI16 / 22

RSI divergenceBullish

MACD divergenceBullish

ATR %+15.11%

ADR %11.16%

52w high3.79

52w low0.1560

From 52w high-95.73%

Above 52w low+3.78%

New 52w highNo

SqueezeOff

Bollinger width42.23%

%B0.29

Donchian pos23.00%

Donchian high0.2352

Donchian low0.1400

AVWAP (52w high)0.6890

vs AVWAP high-76.50%

AVWAP (52w low)0.1679

vs AVWAP low-3.55%

OBV trendDown

Chaikin MF (20)-0.16

Today vs 20d1.21×

Avg vol (14d)17.4M

Avg vol (20d)16.06M

Avg $ vol (20d)2.82M

Market cap38M

RS 3m (vs SPY)-63.26%

RS 6m (vs SPY)-102.82%

RS line new highNo

Trend template0/8

Technical rank3.9

1 week-9.55%

1 month-26.41%

3 months-57.56%

6 months-95.71%

1 year-88.27%

YTD-94.38%

P/E-0.22

P/B-0.24

P/S0.78

P/FCF-0.22

EPS-0.7500

Div yield—

ROE105.50%

ROA-132.17%

Debt/Eq0.00

Current2.20

EV/EBITDA0.02

Gross margin—

Net margin-351.49%

Rev growth-57.74%

EPS growth-201.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-3.03M

Revenue16.95M

Net income-46.66M

Gross profit—

Free cash flow-171.34M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out488.85M

Employees162

ListedFri, Feb 8, 2019

Free float213.87M

Float %92.4%

Short interest62.82M

Days to cover2.8d

Short volume53.4%

Squeeze score66 / 100

Next earningsTue, Aug 4, 2026 (40d)

EPS forecast−$0.10 · 3 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank3.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3675

Support0.1476

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GOSS

All disclosures →

No recent disclosed trades by Congress in GOSS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GOSS · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Quisel John D Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Drynan Skye Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Daniel Thomas O Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Milligan Sandra Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Nathan Steven D Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05
Cox Russell J. Director · Stock Option (Right to Buy) · 2026-06-04	Grant	115K	$0	2026-06-04	2026-06-05

SEC filings

EDGAR filings in GOSS · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.